Title:	SARS-CoV-2 or Covid-19 : the search for alternative treatment for the new coronavirus
Authors:	Araújo, Joabe Lima Azevedo, Vitória Santos Araújo, Adrielle de Sá Araújo, Jessé Lima Araújo, Ingryde Lima Sousa, Lucas Aires de Santos, Gardênia Taveira Silva, Welson de Freitas Pinheiro, Ana Maria Alves Santos, Gabel Taveira Cruz, Hugo Vitor Menezes Passos, Ionara Nayana Gomes Rocha, Jefferson Almeida
Assunto::	SARS-CoV-2 Coronavirus Epidemias Covid-19 Tratamento Medicamentos Vacinas
Issue Date:	30-Jun-2020
Publisher:	International Journal of Development Research
Citation:	ARAÚJO. Joabe Lima et al. SARS-CoV-2 or Covid-19: the search for alternative treatment for the new coronavirus. International Journal of Development Research, v. 10, n. 06, p. 37117-37122, jun. 2020. DOI: https://doi.org/10.37118/ijdr.19286.06.2020. Disponível em: http://www.journalijdr.com/sars-cov-2-or-covid-19-search-alternative-treatment-new-coronavirus. Acesso em: 08 jan. 2021.
Abstract:	SARS-CoV-2 belongs to the Coronaviridae family and of the order Nidovirales, which has positive non-segmented RNA, of the enveloped type that causes a severe acute respiratory syndrome in humans, which has already infected more than 9 million people worldwide, leading to 496,075 deaths by June 27, 2020, making the search for alternative treatment for this pathogen urgent. Thus, this study aimed to conduct a bibliographic survey of research that presents treatment alternatives for the new coronavirus. Thus, a qualitative and descriptive cross-sectional study was carried out, and a comparative analysis was carried out with the prospective results achieved as presented in a study carried out by Reis and collaborators. Publications from the last 7 months were considered, that is, from December 2019 to June 2020, the period in which studies of SARS-CoV-2 started. In this way, a total of 4,898 studies related to the treatment alternative for SARS-CoV-2 were found, in which the drugs remdesivir, atazanavir, favipiravir, EIDD-2801 and hydroxychloroquine associated with azithromycin stand out, where they presented attractive preliminary results and are recommended for clinical studies in humans as an alternative way of coping with the new coronavirus.
Licença::	Copyright © 2020, Joabe Lima Araújo et al., 2020. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI:	https://doi.org/10.37118/ijdr.19286.06.2020
Appears in Collections:	Artigos publicados em periódicos e afins UnB - Covid-19

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.